Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Correlation Between 18F-Fluorodeoxyglucose Uptake and Epidermal Growth Factor Receptor Mutations in Advanced Lung Cancer

Correlation Between 18F-Fluorodeoxyglucose Uptake and Epidermal Growth Factor Receptor Mutations... Nucl Med Mol Imaging (2012) 46:169–175 DOI 10.1007/s13139-012-0142-z ORIGINAL ARTICLE Correlation Between F-Fluorodeoxyglucose Uptake and Epidermal Growth Factor Receptor Mutations in Advanced Lung Cancer Yun-Jung Choi & Byoung Chul Cho & Yong Hyu Jeong & Hyo Jung Seo & Hyun Jeong Kim & Arthur Cho & Jae Hoon Lee & Mijin Yun & Tae Joo Jeon & Jong Doo Lee & Won Jun Kang Received: 22 March 2012 /Revised: 30 April 2012 /Accepted: 2 May 2012 /Published online: 7 June 2012 Korean Society of Nuclear Medicine 2012 Abstract exon 21 mutation or wild type (P00.003 and 0.009, respec- Purpose Mutations in the epidermal growth factor receptor tively). The EGFR mutation showed prolonged overall sur- (EGFR) gene have been identified as potential targets for the vival (OS) compared to wild-type tumors (P00.004). There treatment and prognostic factors for non-small cell lung was no significant difference in survival according to SUV- cancer (NSCLC). We assessed the correlation between fluo- max. Both OS and progression-free survival of patients with a rodeoxyglucose (FDG) uptake and EGFR mutations, as well mutation in exon 19 were significant longer than in patients as their prognostic implications. with wild-type tumors. Methods A total of 163 patients with http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Nuclear Medicine and Molecular Imaging Springer Journals

Correlation Between 18F-Fluorodeoxyglucose Uptake and Epidermal Growth Factor Receptor Mutations in Advanced Lung Cancer

Loading next page...
 
/lp/springer-journals/correlation-between-18f-fluorodeoxyglucose-uptake-and-epidermal-growth-a2HrJug7Q2

References (32)

Publisher
Springer Journals
Copyright
Copyright © 2012 by Korean Society of Nuclear Medicine
Subject
Medicine & Public Health; Cardiology; Imaging / Radiology; Oncology; Nuclear Medicine; Orthopedics
ISSN
1869-3474
eISSN
1869-3482
DOI
10.1007/s13139-012-0142-z
pmid
24900056
Publisher site
See Article on Publisher Site

Abstract

Nucl Med Mol Imaging (2012) 46:169–175 DOI 10.1007/s13139-012-0142-z ORIGINAL ARTICLE Correlation Between F-Fluorodeoxyglucose Uptake and Epidermal Growth Factor Receptor Mutations in Advanced Lung Cancer Yun-Jung Choi & Byoung Chul Cho & Yong Hyu Jeong & Hyo Jung Seo & Hyun Jeong Kim & Arthur Cho & Jae Hoon Lee & Mijin Yun & Tae Joo Jeon & Jong Doo Lee & Won Jun Kang Received: 22 March 2012 /Revised: 30 April 2012 /Accepted: 2 May 2012 /Published online: 7 June 2012 Korean Society of Nuclear Medicine 2012 Abstract exon 21 mutation or wild type (P00.003 and 0.009, respec- Purpose Mutations in the epidermal growth factor receptor tively). The EGFR mutation showed prolonged overall sur- (EGFR) gene have been identified as potential targets for the vival (OS) compared to wild-type tumors (P00.004). There treatment and prognostic factors for non-small cell lung was no significant difference in survival according to SUV- cancer (NSCLC). We assessed the correlation between fluo- max. Both OS and progression-free survival of patients with a rodeoxyglucose (FDG) uptake and EGFR mutations, as well mutation in exon 19 were significant longer than in patients as their prognostic implications. with wild-type tumors. Methods A total of 163 patients with

Journal

Nuclear Medicine and Molecular ImagingSpringer Journals

Published: Jun 7, 2012

There are no references for this article.